scholarly article | Q13442814 |
P50 | author | Kathleen M. Weber | Q112651762 |
Mardge H. Cohen | Q112651887 | ||
Phyllis C Tien | Q112652034 | ||
Elizabeth T Golub | Q112652360 | ||
Audrey L. French | Q121210945 | ||
P2093 | author name string | Anjali Sharma | |
Marshall J Glesby | |||
William Meyer | |||
Daniel Merenstein | |||
Denis Agniel | |||
Oluwatoyin M Adeyemi | |||
Maria C Villacres | |||
P2860 | cites work | High prevalence of severe vitamin D deficiency in combined antiretroviral therapy-naive and successfully treated Swiss HIV patients | Q43157193 |
Efavirenz and bone health. | Q46006592 | ||
High frequency of vitamin D deficiency in ambulatory HIV-Positive patients | Q46183566 | ||
Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality | Q46523052 | ||
Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States | Q46547776 | ||
Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study | Q46549314 | ||
Vitamin D deficiency among HIV type 1-infected individuals in the Netherlands: effects of antiretroviral therapy. | Q51678383 | ||
Deficiency of 25-hydroxyvitamin D in male HIV-positive patients: A descriptive cross-sectional study | Q60291323 | ||
Low vitamin D among HIV-infected adults: prevalence of and risk factors for low vitamin D Levels in a cohort of HIV-infected adults and comparison to prevalence among adults in the US general population | Q64129102 | ||
Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease | Q79337877 | ||
Severe vitamin D deficiency diagnosed after introduction of antiretroviral therapy including efavirenz in a patient living at latitude 59 degrees N | Q80217296 | ||
Relationship between vitamin D status, parathyroid hormone levels and bone mineral density in patients with chronic kidney disease stages 3 and 4 | Q80501439 | ||
The Women's Interagency HIV Study. WIHS Collaborative Study Group | Q95805016 | ||
Update in vitamin D | Q22306211 | ||
Vitamin d, adiposity, and calcified atherosclerotic plaque in african-americans | Q24621603 | ||
Vitamin D deficiency | Q27860616 | ||
Active serum vitamin D levels are inversely correlated with coronary calcification | Q28250542 | ||
Vitamin D deficiency: a worldwide problem with health consequences. | Q30368744 | ||
Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey | Q31115409 | ||
Vitamin D status of HIV-infected women and its association with HIV disease progression, anemia, and mortality | Q33526366 | ||
Vitamin D, race, and cardiovascular mortality: findings from a national US sample | Q33594288 | ||
Decreased bioavailability of vitamin D in obesity | Q33916095 | ||
The Women's Interagency HIV Study: an observational cohort brings clinical sciences to the bench | Q34045522 | ||
The noncalciotropic actions of vitamin D: recent clinical developments | Q34532994 | ||
Intakes of calcium and vitamin D and breast cancer risk in women | Q34579813 | ||
Vitamin D deficiency and risk of cardiovascular disease | Q34586829 | ||
Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. | Q34967426 | ||
25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study | Q37035497 | ||
Frequency of leisure-time physical activity and serum 25-hydroxyvitamin D levels in the US population: results from the Third National Health and Nutrition Examination Survey | Q37305912 | ||
The Rapidly Evolving Research on Vitamin D Among HIV-Infected Populations | Q37838799 | ||
Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988-1994. | Q39606361 | ||
Vitamin D status in adolescents and young adults with HIV infection | Q39754515 | ||
Do we still need a cohort study of women with HIV infection? | Q40866620 | ||
Association between initiation of antiretroviral therapy with efavirenz and decreases in 25-hydroxyvitamin D. | Q43048034 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | HIV | Q15787 |
vitamin B12 deficiency | Q3234995 | ||
vitamin D deficiency | Q4138762 | ||
P304 | page(s) | 197-204 | |
P577 | publication date | 2011-07-01 | |
P1433 | published in | Journal of Acquired Immune Deficiency Syndromes | Q6294722 |
P1476 | title | Vitamin D deficiency in HIV-infected and HIV-uninfected women in the United States | |
P478 | volume | 57 |
Q34076892 | 25-Hydroxyvitamin D insufficiency and deficiency is associated with HIV disease progression and virological failure post-antiretroviral therapy initiation in diverse multinational settings |
Q36060389 | Association among vitamin D, oral candidiasis, and calprotectinemia in HIV. |
Q38095828 | Bone health and human immunodeficiency virus infection |
Q31124706 | Bone turnover and bone mineral density in HIV-1 infected Chinese taking highly active antiretroviral therapy -a prospective observational study |
Q35154069 | Change in vitamin d levels occurs early after antiretroviral therapy initiation and depends on treatment regimen in resource-limited settings |
Q36074219 | Circulating vitamin D correlates with serum antimüllerian hormone levels in late-reproductive-aged women: Women's Interagency HIV Study |
Q54224147 | Continued Interest and Controversy: Vitamin D in HIV. |
Q36736469 | Cross-sectional study of vitamin D levels, immunologic and virologic outcomes in HIV-infected adults. |
Q41644519 | Effect of a monthly dose of calcidiol in improving vitamin D deficiency and secondary hyperparathyroidism in HIV-infected patients |
Q39673591 | High prevalence of vitamin D deficiency in HIV-infected adults: what are the future research questions? |
Q46543775 | Higher vitamin D levels in HIV-infected out-patients on treatment with boosted protease inhibitor monotherapy |
Q36177899 | Hyperparathyroidism and complications associated with vitamin D deficiency in HIV-infected adults in New York City, New York. |
Q36381307 | Interventions to address chronic disease and HIV: strategies to promote exercise and nutrition among HIV-infected individuals. |
Q40197765 | Is serum 25-hydroxyvitamin D associated with depressive symptoms and suicidal ideation in Korean adults? |
Q89695724 | Low maternal vitamin D is associated with increased risk of congenital and peri/postnatal transmission of Cytomegalovirus in women with HIV |
Q35706037 | Low vitamin D status among pregnant Latin American and Caribbean women with HIV Infection |
Q37153745 | Number of Primary Care Visits Associated with Screening for Cervical Dysplasia among Women with HIV Infection in Harris County, Texas, United States of America |
Q37379906 | Potential mechanisms for racial and ethnic differences in antimüllerian hormone and ovarian reserve |
Q37156878 | Prevalence and Factors Associated with Vitamin D Deficiency and Hyperparathyroidism in HIV-Infected Patients Treated in Barcelona. |
Q40563423 | Prevalence and risk factors for efavirenz-based antiretroviral treatment-associated severe vitamin D deficiency: A prospective cohort study |
Q40680683 | Prevalence of hypovitaminosis D and its association with oral lesions in HIV-infected Brazilian adults. |
Q42229887 | Prognostic value of vitamin D level for all-cause mortality, and association with inflammatory markers, in HIV-infected persons |
Q38836871 | Protecting bone in long-term HIV positive patients receiving antiretrovirals |
Q38450420 | Risk factors associated with hypovitaminosis D in HIV/aids-infected adults. |
Q28538127 | Risk factors for vitamin D deficiency among HIV-infected and uninfected injection drug users |
Q35510622 | Risk factors for vitamin D deficiency among veterans with and without HIV infection |
Q37111446 | Short communication: High prevalence of vitamin D deficiency in HIV-infected and HIV-uninfected pregnant women |
Q34404878 | Substantial effect of efavirenz monotherapy on bilirubin levels in healthy volunteers |
Q59352745 | The impact of Middle Eastern Origin, HIV, HCV, and HIV/HCV co-infection in the development of hypovitaminosis D in adults |
Q38005045 | Therapeutic options for low bone mineral density in HIV-infected subjects |
Q41659730 | Ultraviolet index and location are important determinants of vitamin D status in people with human immunodeficiency virus |
Q40517679 | Vitamin D Deficiency and Metabolism in HIV-Infected and HIV-Uninfected Men in the Multicenter AIDS Cohort Study |
Q36447199 | Vitamin D Levels, Natural H1N1 Infection and Response to H1N1 Vaccine among HIV-Infected Individuals |
Q39026377 | Vitamin D and Infectious Diseases: Simple Bystander or Contributing Factor? |
Q36816930 | Vitamin D and bone loss in HIV |
Q36899859 | Vitamin D and insulin resistance in non-diabetic women's interagency HIV study participants |
Q36408936 | Vitamin D deficiency and its association with low bone mineral density, HIV-related factors, hospitalization, and death in a predominantly black HIV-infected cohort |
Q54254278 | Vitamin D deficiency and periodontal clinical attachment loss in HIV-seropositive women: A secondary analysis conducted in the Women's Interagency HIV Study (WIHS). |
Q37155210 | Vitamin D deficiency and persistent proteinuria among HIV-infected and uninfected injection drug users |
Q42939810 | Vitamin D deficiency in HIV-infected and -uninfected women in the United States |
Q33615509 | Vitamin D insufficiency and subclinical atherosclerosis in non-diabetic males living with HIV |
Q37518789 | Vitamin D insufficiency may impair CD4 recovery among Women's Interagency HIV Study participants with advanced disease on HAART. |
Q35245597 | Vitamin D status and its association with morbidity including wasting and opportunistic illnesses in HIV-infected women in Tanzania |
Q37625118 | Vitamin D status of human immunodeficiency virus-positive patients with advanced liver disease enrolled in the solid organ transplantation in HIV: multi-site study |
Q33603196 | Vitamin D, bone, and HIV infection. |
Search more.